logo
Three Lancashire hospital trusts in 'financial special measures'

Three Lancashire hospital trusts in 'financial special measures'

BBC News06-02-2025

Three out of Lancashire's four acute hospital trusts have been put in the equivalent of financial special measures by NHS England, the BBC can exclusively reveal. The trusts which run the Royal Preston, Chorley, Royal Blackburn, Burnley and Blackpool Victoria hospitals have been told they are going to have to save tens of millions of pounds.The Lancashire and South Cumbria Integrated Care Board (ICB), which funds them, has to make more than £530m in efficiency savings this financial year, potentially cutting some services.An ICB spokesman told BBC North West Tonight they welcomed the additional support from NHS England as they recognised the "severity of the situation".
He added that "dedicated" NHS staff were "working hard under difficult circumstances to continue delivering the best care". The affected trusts, East Lancashire Hospitals Trust, Blackpool Teaching Hospitals NHS Foundation Trust and Lancashire Teaching Hospitals Trust, have already slashed millions of pounds from their budgets and for months there has been a virtual recruitment freeze for non-clinical staff. Last month, East Lancashire Hospitals Trust announced it would be cutting the free bus service between Blackburn, Burnley and Pendle hospitals at the end of March – saving £780,000 a year. A local bus company has since announced a paid-for service running the same route.Meanwhile, at Chorley hospital, a surgical ward which was built less than three years ago is to shut at the end of the financial year.
The announcement prompted a strike by the staff involved, who have been told they will be redeployed. Lancashire Teaching Hospitals Trust said there were plans to repurpose the ward but confirmed that the move would save money.All of the trusts in Lancashire and South Cumbria are funded by the Integrated Care Board, which is in serious financial difficulty. This year it received a total budget of just over £4.5bn, which is used to run the entire health economy in the region, from hospitals to GPs, and it falls short of what the ICB needs to do that.The organisation would need to shave about £700m in costs from the services it currently provides in order to hit that target. NHS England has already agreed that they can overspend by £175m this year, leaving £530m to find.Some of those savings have already been made but NHS England is concerned about progress and has placed the ICB and the three hospital trusts in a form of special measures known as the Recovery Support Programme.
'Dilapidated building'
NHS England said it provided focused assistance to organisations and systems facing the most profound challenges. In practice, this involves national teams going in to identify how things can be run more efficiently and cheaply.But with cuts of about 12% to find this year alone, some services look set to be affected.The Royal Preston Hospital is also in need of ongoing maintenance work. The hospital has previously had to close clinical areas because of flooding and has described parts of the building as "dilapidated".Work was supposed to start on a new building in the early 2030s but last month the government announced that a new hospital might now be 18 years away. The trust has previously announced that it faced a backlog of maintenance work totalling £157m and has since said that this new announcement would mean a "significant" amount of extra cash needed to keep the building useable.
The chief executive of Lancashire and South Cumbria ICB told the BBC that they welcomed the support from NHS England "as we recognise the severity of the situation that we are in".Kevin Lavery said they took responsibility for the challenges they faced and recognised that there was more to be done about their financial position."Despite the hard work of colleagues across our system, we have unfortunately not made the improvements that we had hoped to by this point," he said."I can confidently say that our NHS workforce is dedicated to providing the highest standard of care for our communities and is working hard under difficult circumstances to continue delivering the best care day in, day out."Mr Lavery said the ICB had "an opportunity here to ensure that the support and expertise from this programme helps us to make improvements which will ultimately support our system to deliver high quality, sustainable health services for the people of Lancashire and South Cumbria".
Listen to the best of BBC Radio Lancashire on Sounds and follow BBC Lancashire on Facebook, X and Instagram and watch BBC North West Tonight on BBC iPlayer.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Medical staff who responded to Southport knife attacks honoured by King
Medical staff who responded to Southport knife attacks honoured by King

Western Telegraph

time2 days ago

  • Western Telegraph

Medical staff who responded to Southport knife attacks honoured by King

Paul Smith, a senior paramedic team leader, treated victims at the scene where Bebe King, six, Elsie Dot Stancombe, seven, and Alice Dasilva Aguiar, nine, were murdered and 10 others injured at a Taylor Swift-themed dance class last July. Mr Smith, who works for the North West Ambulance Service, was awarded a British Empire Medal (BEM) for his services to the community in Merseyside after 'he put the needs of the injured before his own safety', the NHS said. I'd like to recognise those staff who were involved in the response to the knife attack in Southport last summer. These awards rightly honour their incredible dedication and commitment in an awful situation Sir Jim Mackey, NHS chief executive Dr George Bramham, who was also a first responder, received the same honour. Martin Johnson and Elizabeth Parsons, who were part of the surgical team in theatre who treated people sent to Southport Hospital after the stabbings, have been given the same medals. Sir Jim Mackey, NHS chief executive, praised the staff for their 'incredible dedication and commitment in an awful situation'. Meanwhile, Reverend Martin Abrams, a spiritual care and chaplaincy manager, has been made a Member of the Order of the British Empire (MBE) for services to the community in Merseyside and west Lancashire. This stands as a legacy of the work to address health inequalities by driving forward a powerful vision of exceptional quality healthcare for all, ensuring equitable access, excellent experience and optimal outcomes Professor Bola Owolabi, NHS England He played a key role in the community after the horrors of the attacks, the health service said. Other NHS staff receiving honours include Professor Bola Owolabi, a GP and director of inequalities at NHS England, who was made a Commander of the Order of the British Empire (CBE) for her services to reducing health inequalities. Professor Owolabi said: 'This stands as a legacy of the work to address health inequalities by driving forward a powerful vision of exceptional quality healthcare for all, ensuring equitable access, excellent experience and optimal outcomes.' Sir Jim added: 'I want to give my heartfelt congratulations to all the people working in the NHS that have received honours, who work tirelessly everyday to care for their patients. 'I'd also like to recognise those staff who were involved in the response to the knife attack in Southport last summer. These awards rightly honour their incredible dedication and commitment in an awful situation. 'The NHS is made up of highly committed and dedicated people that work hard to give the best possible care to patients, and these honours recognise their skill, compassion and bravery.'

World-first 'Trojan horse' drug to be given to blood cancer patients in England
World-first 'Trojan horse' drug to be given to blood cancer patients in England

ITV News

time2 days ago

  • ITV News

World-first 'Trojan horse' drug to be given to blood cancer patients in England

Blood cancer patients in England will be among the first in the world to have access to a new 'Trojan horse' treatment, health officials have announced. Studies suggest the targeted therapy can stop myeloma from progressing by nearly three times as long as existing treatments. It is estimated that around 1,500 patients a year with multiple myeloma – an incurable cancer of the bone marrow – will benefit from the treatment. It comes after the National Institute for Health and Care Excellence (Nice) approved belantamab mafodotin, also known as Blenrep and made by GlaxoSmithKline, for NHS use. NHS England said that it is the first health system in the world to roll out the treatment. Officials said that the drug can now be offered to patients whose cancer has progressed or has not responded to another first-line treatment. The treatment, which is given as an infusion every three weeks along with other cancer drugs, is a type of antibody drug which targets and attaches to cancer cells. It has been dubbed a 'Trojan horse' treatment because it works by being taken into a cancer cell, before releasing a high concentration of a lethal molecule to destroy the cell from inside. 'Myeloma is an aggressive type of blood cancer, but we have seen a steady improvement in the outlook for patients over recent years as we have introduced new targeted therapies,' Professor Peter Johnson, NHS England's national clinical director for cancer, said. 'I am delighted that patients in England will be the first to benefit from this new treatment, which has the potential to keep cancer at bay for years longer, giving people the chance of more precious time with friends and family. 'This treatment could be life-changing for many patients and their families, and that's why it is so important that the NHS continues to secure quick access to the latest, innovative treatments like this, at affordable prices to the taxpayer.' Helen Knight, director of medicines evaluation at Nice, said: 'We're delighted that people in the UK will become among the first in the world to access belantamab mafodotin for this indication. 'This recommendation demonstrates our commitment to getting the best care to patients fast, while ensuring value for the taxpayer.' Trials have suggested that the treatment, in combination with bortezomib and dexamethasone, delayed progression of the disease by an average of three years, compared to just over a year for patients taking commonly used drug daratumumab along with the other treatments. Patient Paul Silvester, 60, from Sheffield, was diagnosed with myeloma in July 2023 and received treatment at the Royal Hallamshire Hospital. The first treatment he was given failed to stop his cancer from progressing so he was given belantamab mafodotin through an early access programme. 'I feel like this treatment has brought the party balloons back in the house. It has been amazing – within the first two or three weeks, after the first dose, I was in remission,' he said. 'It gives me quite a lot of confidence in the drugs and it makes me more optimistic about the future.'I've been feeling well and I'm still quite active – that's what's important in terms of your quality of life. 'One of my daughters is graduating from university in October and it's a goal for me to be there.' Shelagh McKinlay, director of research and advocacy at blood cancer charity Myeloma UK, said: 'It's fantastic to see the UK at the forefront of myeloma treatment. 'We have been working very hard for the last year to get this treatment approved and we know it will transform the lives of thousands of people with myeloma.' Health Minister Karin Smyth said: 'This groundbreaking therapy puts the NHS at the forefront of cancer innovation.'By harnessing cutting-edge 'trojan horse' technology, we're offering new hope to blood cancer patients across the country.'

Ozempic-like weight loss jabs could one day be dished out like statins, says top NHS doctor
Ozempic-like weight loss jabs could one day be dished out like statins, says top NHS doctor

Scottish Sun

time2 days ago

  • Scottish Sun

Ozempic-like weight loss jabs could one day be dished out like statins, says top NHS doctor

Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) WEIGHT loss jabs could one day be dished out like statins, England's top doctor says. Professor Sir Stephen Powis, medical director of NHS England, said in years to come they will get cheaper and may be used to prevent a range of illnesses. 1 NHS' top doctor says weight loss jabs like Mounjaro "will become more widespread" Credit: Alamy But chief medical officer Professor Sir Chris Whitty said they are 'not a get out of jail card' and people must still try to be healthy. GPs will roll out Mounjaro across the country from this month. The injections currently cost the NHS around £100 each but prices are expected to drop over time. Research increasingly shows they have health benefits beyond diabetes and weight loss, potentially including reducing the risks of cancer, dementia and heart diseases. These are not get-out-of-jail cards Professor Sir Chris Whitty Cholesterol-lowering statins have been used for decades to reduce heart attacks and strokes and now cost next to nothing at 3p a pill. Studies suggest they also reduce the risk of dementia, though it is not what they were designed for. Prof Powis said: 'The use of statins is now very different from when they first came out and I've no doubt that will be the same for these drugs. 'I think over time it's highly likely that they will become more widespread. 'I think there will be a combination of increased evidence of positive outcomes and costs dropping, and we will learn better how to deploy them. 'It's not completely unusual for drugs over time to be found to have effects that go over and beyond what they were initially designed for. 'I am not starry-eyed about weight loss drugs but it's very exciting. 'We're in the foothills of learning how to use them.' NHS prescriptions surging NHS use of the jabs is already skyrocketing and official figures show prescriptions in England surged from 1.4million in 2023 to 2.7m in 2024. Doctors spent a total of £269million on them in the latest financial year and more than a million people are estimated to be buying them privately. Prof Whitty said it is important for people to still get help to eat healthily and exercise, as well as taking medicine. He added: 'These are not get out of jail cards. 'What we shouldn't do is use it as an excuse, as a society, not to deal with what is a rising and very serious problem.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store